Literature DB >> 26061470

Network meta-analysis of parametric survival curves.

Mario J N M Ouwens1, Zoe Philips1, Jeroen P Jansen2.   

Abstract

To inform health-care decision-making, treatments are often compared by synthesizing results from a number of randomized controlled trials. The meta-analysis may not only be focused on a particular pairwise comparison, but can also include multiple treatment comparisons by means of network meta-analysis. For time-to-event outcomes such as survival, pooling is typically based on the hazard ratio (HR). The proportional hazards assumption that underlies current approaches of evidence synthesis is not only often implausible, but can also have a huge impact on decisions based on differences in expected outcomes, such as cost-effectiveness analysis. The application of a constant HR implies the assumption that the treatment only has an effect on one characteristic of the survival distribution, while commonly used survival distributions, like the Weibull distribution, have both a shape and a scale parameter. Instead of using constant HRs, this paper proposes meta-analysis of treatment effects based on the shape and scale parameters of parametric survival curves. The model for meta-analysis is extended for network meta-analysis and illustrated with an example.
Copyright © 2011 John Wiley & Sons, Ltd. Copyright © 2011 John Wiley & Sons, Ltd.

Keywords:  indirect comparisons; network meta‐analysis; parametric survival; treatment effect

Year:  2011        PMID: 26061470     DOI: 10.1002/jrsm.25

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  33 in total

1.  Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma.

Authors:  Shannon Cope; Kabirraaj Toor; Evan Popoff; Rafael Fonseca; Ola Landgren; María-Victoria Mateos; Katja Weisel; Jeroen Paul Jansen
Journal:  Value Health       Date:  2020-04-06       Impact factor: 5.725

Review 2.  Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials.

Authors:  Brian R Matlaga; Jeroen P Jansen; Lisa M Meckley; Thomas W Byrne; James E Lingeman
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

3.  Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?

Authors:  John W Stevens
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

Review 4.  Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

Authors:  Pascale Dequen; Paul Lorigan; Jeroen P Jansen; Marc van Baardewijk; Mario J N M Ouwens; Srividya Kotapati
Journal:  Oncologist       Date:  2012-09-28

Review 5.  Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Joanna Picot; Neelam Kalita; Wendy Gaisford; Petra Harris; Oluchukwu Onyimadu; Keith Cooper
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

6.  Incorporating lag time to benefit into prevention decisions for older adults.

Authors:  Sei J Lee; Rosanne M Leipzig; Louise C Walter
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

7.  Two-stage meta-analysis of survival data from individual participants using percentile ratios.

Authors:  Jessica K Barrett; Vern T Farewell; Fotios Siannis; Jayne Tierney; Julian P T Higgins
Journal:  Stat Med       Date:  2012-07-24       Impact factor: 2.373

8.  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Authors:  Patricia Guyot; A E Ades; Mario J N M Ouwens; Nicky J Welton
Journal:  BMC Med Res Methodol       Date:  2012-02-01       Impact factor: 4.615

9.  Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials.

Authors:  Victoria Tang; W John Boscardin; Irena Stijacic-Cenzer; Sei J Lee
Journal:  BMJ       Date:  2015-04-16

10.  Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes.

Authors:  Jeroen P Jansen; Shannon Cope
Journal:  BMC Med Res Methodol       Date:  2012-10-08       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.